RECRUITING

Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

Description

The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.

Conditions

Study Overview

Study Details

Study overview

The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.

Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

Condition
Blepharoplasty
Intervention / Treatment

-

Contacts and Locations

Miami

Center for Excellence in Eye Care, Miami, Florida, United States, 33176

Alexandria

Vance Thompson Vision, Alexandria, Minnesota, United States, 56308

Kingston

Eye Care Specialists, Kingston, Pennsylvania, United States, 18704

Sioux Falls

Vance Thompson Vision, Sioux Falls, South Dakota, United States, 57108

Kenosha

The Eye Centers of Racine and Kenosha, LTD, Kenosha, Wisconsin, United States, 53142

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Provide signed written consent prior to participation in any study-related procedures.
  • 2. Ability, comprehension, and willingness to follow study instructions, and likely to complete all study visits.
  • 3. Male or female adults, ≥ 35 years old at the Preoperative Visit
  • 4. Willing to return for required follow-up visits.
  • 5. Subjects with excess eyelid skin are eligible to undergo the procedure in the opinion of the investigator.
  • 6. Female subjects must be 1-year postmenopausal, surgically sterilized, or, if of childbearing potential, have a negative urine pregnancy test at the Preoperative Visit. Women of childbearing potential must use an acceptable form of contraception throughout the study. Acceptable methods include at least one of the following: intrauterine (intrauterine device), hormonal (oral, injection, patch, implant, ring), barrier with spermicide (condom, diaphragm), or abstinence.
  • 1. Subjects with a current Ptosis diagnosis
  • 2. Subjects with a history of Graves' Disease
  • 3. Subjects with Myasthenia Gravis
  • 4. Subjects that in the opinion of the investigator are anatomically not conducive to using devices (e.g., heavy brow, severe hollowing of the upper eyelid, history of ocular or orbital trauma).
  • 5. Subjects that have had any previous surgery eyelid or eyebrow region.
  • 6. Use of anticoagulation therapy, including, but not limited to Aspirin, NSAIDS, Ibuprofen within 7 days and Xarelto, Warfarin, Enoxaparin, Plavix within 3 days prior to planned study procedure.
  • 7. Active or recent (within 3 months) tobacco user
  • 8. Allergy to adhesive glue
  • 9. Participation in any study of an investigational, interventional product within 30 days prior to the Preoperative Visit or at any time during the study period.
  • 10. Pregnant or nursing females.

Ages Eligible for Study

35 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Osheru Inc.,

Study Record Dates

2025-12